Doctor Kamal Matli

IMM, Paris (France)

Follow

Contributor content

Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study

Presentation

Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study

ESC 365 is supported by

novartis

Explore sponsored resources